These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 24163075)

  • 41. Pattern Recognition Receptors and Control of Innate Immunity: Role of Nucleic Acids.
    Fischer S
    Curr Pharm Biotechnol; 2018; 19(15):1203-1209. PubMed ID: 30636600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Damage-Associated Molecular Patterns and the Systemic Immune Consequences of Severe Thermal Injury.
    Comish PB; Carlson D; Kang R; Tang D
    J Immunol; 2020 Sep; 205(5):1189-1197. PubMed ID: 32839211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
    Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
    Front Immunol; 2020; 11():575890. PubMed ID: 33042158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation.
    McCoy KL
    Mediators Inflamm; 2016; 2016():5831315. PubMed ID: 27597805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptors and kidney diseases.
    Eleftheriadis T; Lawson BR
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):191-201. PubMed ID: 19601879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innate immunity and cardiomyocytes in ischemic heart disease.
    Lin L; Knowlton AA
    Life Sci; 2014 Mar; 100(1):1-8. PubMed ID: 24486305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.
    Diaz-Ricart M; Torramade-Moix S; Pascual G; Palomo M; Moreno-Castaño AB; Martinez-Sanchez J; Vera M; Cases A; Escolar G
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32492843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats.
    Bomfim GF; Echem C; Martins CB; Costa TJ; Sartoretto SM; Dos Santos RA; Oliveira MA; Akamine EH; Fortes ZB; Tostes RC; Webb RC; Carvalho MH
    Life Sci; 2015 Feb; 122():1-7. PubMed ID: 25498891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):73-87. PubMed ID: 22074784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Commensal microflora and endogenous inductors of pathophysiological reactions of innate immunity].
    Bondarenko VM; Likhoded VG; Fialkina SV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (1):81-5. PubMed ID: 25842958
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Injury to allografts: innate immune pathways to acute and chronic rejection.
    Land WG
    Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues.
    Shokoples BG; Paradis P; Schiffrin EL
    Hypertens Res; 2024 May; ():. PubMed ID: 38778172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insight into the mechanisms regulating immune homeostasis in health and disease.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2011 Mar; 29(1):1-14. PubMed ID: 21560483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DAMP-sensing receptors in sterile inflammation and inflammatory diseases.
    Gong T; Liu L; Jiang W; Zhou R
    Nat Rev Immunol; 2020 Feb; 20(2):95-112. PubMed ID: 31558839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial damage-associated molecular patterns and vascular function.
    Wenceslau CF; McCarthy CG; Szasz T; Spitler K; Goulopoulou S; Webb RC;
    Eur Heart J; 2014 May; 35(18):1172-7. PubMed ID: 24569027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Research Progress of Immunity Mechanism in Hypertension].
    Liu LZ; He X; Xu M; Yu XJ; Zang WJ
    Sheng Li Ke Xue Jin Zhan; 2016 Aug; 47(4):255-9. PubMed ID: 29888895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PAMPs and DAMPs: signal 0s that spur autophagy and immunity.
    Tang D; Kang R; Coyne CB; Zeh HJ; Lotze MT
    Immunol Rev; 2012 Sep; 249(1):158-75. PubMed ID: 22889221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innate and Innate-Like Immune System in Hypertension and Vascular Injury.
    Higaki A; Caillon A; Paradis P; Schiffrin EL
    Curr Hypertens Rep; 2019 Jan; 21(1):4. PubMed ID: 30659373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
    Lundberg AM; Yan ZQ
    Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.
    Mahaling B; Low SWY; Beck M; Kumar D; Ahmed S; Connor TB; Ahmad B; Chaurasia SS
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.